Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early evidence that Recursion's platform can generate novel, biologically validated tar ...
Spread the loveā€œ`html You’ve meticulously crafted your questionnaire, honed your branching logic, and now you’re ready to ...